Results for tag: "Linzess"

Linzess is a gastrointestinal drug used to treat irritable bowel syndrome with constipation (IBS-C) and chronic idiopathic constipation (CIC). It is a guanylate cyclase-C agonist, which works by increasing the secretion of fluid and electrolytes into the intestine, resulting in softer stools and easier passage. It is available in capsule form and is taken orally once daily. Linzess is a relatively new drug, having been approved by the US Food and Drug Administration (FDA) in 2012. It is marketed by Allergan, a subsidiary of AbbVie, and is available in the United States, Canada, and Europe. It is also available in generic form in some countries. The Linzess market is highly competitive, with several companies offering similar products. These include Ironwood Pharmaceuticals, Synergy Pharmaceuticals, and Salix Pharmaceuticals. Other companies in the market include AstraZeneca, Daiichi Sankyo, and Shire. Show Less Read more